Abstract
Studies of susceptibility, development of resistance, and synergy were performed with 32 antimicrobics againstClostridium difficile strains. A microtiter technique was used to demonstrate the in vitro activities of 40C. difficile isolates. Rifampin inhibited 73% of the strains at a concentration of ≤0.06 μg/ml, and metronidazole inhibited 90% at 0.5 μg/ml. Penicillin, vancomycin, cephaloridine, and chloramphenicol were also active. Development of resistance to penicillin or chloramphenicol was not found, but vancomycin, methicillin, and minocycline showed development of low levels of resistance. Rifampin in combination with erythromycin, methicillin, or penicillin was synergistic against more than 90% of theC. difficile isolates. Rifampin-ampicillin was synergistic against 85%, and vancomycin-metronidazole was synergistic against 68% of the isolates.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Literature Cited
Bartlett, J. G., Tedesco, F. J., Shull, S., Lowe, B., Chang, T. 1980. Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis. Gastroenterology78:431–434.
Dzink, J., Bartlett, J. G. 1980. In vitro susceptibility ofClostridium difficile isolates from patients with antibiotic-associated diarrhea or colitis. Antimicrobial Agents and Chemotherapy17:695–698.
Fekety, R. 1979. Prevention and treatment of antibiotic-associated colitis, pp. 276–279. In: Schlessinger, D. (ed.), Microbiology—1979. Washington, D.C.: American Society for Microbiology.
George, W. L., Kirby, B. D., Sutter, V. L., Finegold, S. M. 1979. Antimicrobial susceptibility ofClostridium difficile, pp. 267–271. In: Schlessinger, D. (ed.), Microbiology—1979. Washington, D.C.: American Society for Microbiology.
George, W. L., Volpicelli, N. A., Stiner, D. B., Richman, D. D., Liechty, E. J., Mok, H. Y., Rolfe, R. D., Finegold, S. M. 1979. Relapse of pseudomembraneous colitis after vancomycin therapy. New England Journal of Medicine301:414–415.
Grüneberg, R. N., Emmerson, A. M. 1980. Prevention of emergence of bacterial resistance by combination of two antibiotics: Rifampicin and trimethoprim. Journal of Antimicrobial Chemotherapy6:349–356.
Larson, H. E. 1979. Pseudomembranous colitis is an infection. Journal of Infection1:221–226.
Rampling, A., Warren, R. E., Sykes, H. V. 1980. Relapse ofClostridium colitis after vancomycin therapy. Journal of Antimicrobial Chemotherapy6:551–552.
Ritchie, P. H., Pennington, C. R. 1980. Pseudomembranous colitis. Scottish Medical Journal25:278–280.
Tytgat, F. 1980. Fréquence d'isolement deClostridium difficile dans les selles de malades hospitalisés: Sensibilité aux antibiotiques des souches isolées. Annales de Microbiologie131B:11–20.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ensminger, P.W., Counter, F.T., Thomas, L.J. et al. Susceptibility, resistance development, and synergy of antimicrobial combinations againstClostridium difficile . Current Microbiology 7, 59–62 (1982). https://doi.org/10.1007/BF01570982
Issue Date:
DOI: https://doi.org/10.1007/BF01570982